Research has demonstrated there is a link between ADHD symptoms and dopamine signalling in the brain. Dopamine is most commonly recognized as the mood-boosting neurotransmitter that is involved in feelings of pleasure and reward.
Dopamine also plays a role in executive function, motivation, attention span and the ability to concentration. Low dopamine levels in the brain, excess levels of dopamine transporters and dysfunction of dopamine receptors have all been hypothesized as causes of ADHD.
Many medications used to treat ADHD work by affecting dopamine levels in the brain. Stimulant drugs like Adderall and Ritalin cause a surge of dopamine to be released from neurons, resulting in a short-term spike of dopaminergic activity.
While this can improve attention and focus temporarily, it often results in dopamine deficiency after the effects of the drugs have worn off. This can cause negative side effects and dependence, which is why many seek out natural ADHD remedies that can optimize dopamine levels with a lower risk of side effects.



- Supports energy & motivation
- Promotes focus & mental clarity
- Improves mood & stress response
ADHD and Dopamine Function in the Brain
Related Topics
Much evidence suggests that norepinephrine and dopamine play key roles in thinking, attention, memory and learning. They help us to sustain our thoughts, focus more effectively and prolong our alertness, motivation and effort toward given tasks.
Dopamine is the precursor of norepinephrine inside the brain. DA (C8H11NO2) and NE (C8H11NO3) are quite similar in molecular structure. The only difference is the addition of a hydroxyl group for NE.
However, each has distinct origin sources and projection pathways in the brain. With selective alterations, each demonstrates unique behavioral effects.
Both are involved in neuronal signalling within the prefrontal cortex area of the brain, which is responsible for executive function.
The prefrontal cortex controls the feelings, behaviors and thoughts of working memory which are directly related to ADHD markers including:
- Inappropriate social behaviors;
- Failure to self-monitor actions;
- Failure to plan for the future;
- Lacking attention;
ADHD and dopamine imaging studies show difficulties in these prefrontal functions. These dysfunctions are believed to cause most ADHD behavioral symptoms.
Common Treatment for ADHD
ADHD affects roughly 10% of children and 4% of adults in the world. In children, ADHD symptoms often include social dysfunction, learning disabilities, low self-confidence and higher risks for develop substance abuse problems.
Millions of children with ADHD are treated with stimulant drugs. Roughly 75% of children and 70% of adults with ADHD are given stimulant drugs like Adderall, Ritalin, Focalin, Evekeo, Vyvanse and Concerta.
It is estimated that about 30% of children using these medications either do not respond to them or develop adverse side effects. A few of these possible adverse effects include pounding heartbeat, swollen face, suicidal thoughts/actions, hallucinations, severe headaches and seizures.
ADHD, Dopamine and the Reward Cascade
Most dopamine pathways inside the brain originate in the VTA (ventral tegmental area). Numerous cortical projections travel through various pathways which modulate motor movements, emotions and perceptions of pleasure and reward.
The reward pathway is largely located in an area of the basal forebrain called the nucleus accumbens. ADHD and dopamine research often centers on this pathway.
Many people with ADHD report that they can only sustain focus on topics or objects that interest them personally. They have much difficulty paying attention to anything that is not intrinsically interesting; even though it may be very important for any number of reasons.
ADHD researchers hopes to discover ways that dopamine can help to modulate interest in important stimuli.
Dopamine pathways that extend to the mesocortex are believed to modulate attention and motivation. They also regulate how we relate what we are focusing on, problem solving and working memory.
Dopamine projections to these pathways control processes which suppress distractions. They also inhibit improper behavioral expressions, like those commonly seen in ADHD.
Many people with ADHD have difficulties with controlling their reactions. They may fidget and seem unable to keep quiet, even in delicate situations. They may inappropriately and spontaneously express their thoughts and feelings regardless of the setting.
Dopamine projections in the mesocortical pathway help to inhibit these expressions by allowing people to sustain focus and weigh options before acting.
ADHD and Dopamine Research
Animal research shows that very small alterations in catecholamine levels can yield extreme changes in the capacity of the prefrontal cortex to modulate behavior.
Maintaining appropriate levels of DA and NE is imperative for prefrontal cortex efficacy. It is believed that optimizing catecholamine levels can improve ADHD symptoms like motor hyperactivity and impulsivity.
Increasing Dopamine Naturally
Adopting certain healthy lifestyle habits can help to naturally elevate dopamine levels. Choosing water-rich, protein-rich, low-fat, low-sugar foods helps to provide the raw materials the body needs to manufacture natural dopamine.
Daily exercise and effective stress coping methods are also very important. Supplements can also be used to increase dopamine levels, such as L-Phenylalanine, L-Tyrosine and Mucuna Pruriens.
By encouraging the body to increase dopamine synthesis and secretion, norepinephrine levels may be subsequently elevated. Over time, ensuring adequate availability of these two powerful neurotransmitters may help to naturally combat the symptoms of ADHD.
Conclusions
Attention deficit hyperactivity disorder is traditionally treated with stimulant drugs. However, these drugs may not improve the underlying conditions that cause ADHD and some experience serious side effects.
There is a clear link between optimal dopamine levels and improving focus and attention. Non-stimulant therapies that safely increase dopamine for those with ADHD may present safer and more effective symptom management in the long term.
A number of other natural supplements have also been explored for this benefits for ADHD symptoms. Fish Oil, Ginkgo Biloba, Vinpocetine and Choline have all demonstrated positive effects with a low risk of side effects.
- Gold MS1, Blum K, Oscar-Berman M, Braverman ER. Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children? Postgrad Med. 2014 Jan;126(1):153-77. doi: 10.3810/pgm.2014.01.2735.
- Liju, Vijayastelter B., Kottarapat Jeena, and Ramadasan Kuttan. "An Evaluation of Antioxidant, Anti-Inflammatory, and Antinociceptive Activities of Essential Oil from Curcuma Longa. L." Indian Journal of Pharmacology 43.5 (2011): 526–531. PMC. Web. 7 Apr. 2016.
- Wing VC1, Payer DE2, Houle S3, George TP4, Boileau I2. Measuring cigarette smoking-induced cortical dopamine release: A [¹¹C]FLB-457 PET study. Neuropsychopharmacology. 2015 May;40(6):1417-27. doi: 10.1038/npp.2014.327. Epub 2014 Dec 15.
- Kempster PA1, Gibb WR, Stern GM, Lees AJ. Asymmetry of substantia nigra neuronal loss in Parkinson's disease and its relevance to the mechanism of levodopa related motor fluctuations. J Neurol Neurosurg Psychiatry. 1989 Jan;52(1):72-6.
- Zawilska JB1. [Dopamine receptors--structure, characterization and function]. Postepy Hig Med Dosw. 2003;57(3):293-322.
- Jaber M1, Robinson SW, Missale C, Caron MG. Dopamine receptors and brain function. Neuropharmacology. 1996;35(11):1503-19.
- Jiang H1, Wang J2, Rogers J3, Xie J4. Brain Iron Metabolism Dysfunction in Parkinson's Disease. Mol Neurobiol. 2016 Apr 2. [Epub ahead of print]
- Arnsten AF1, Girgis RR2, Gray DL3, Mailman RB4. Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia. Biol Psychiatry. 2016 Jan 18. pii: S0006-3223(16)00044-5. doi: 10.1016/j.biopsych.2015.12.028. [Epub ahead of print]
- Arnsten AF1, Wang M2, Paspalas CD2. Dopamine's Actions in Primate Prefrontal Cortex: Challenges for Treating Cognitive Disorders. Pharmacol Rev. 2015 Jul;67(3):681-96. doi: 10.1124/pr.115.010512.
- Torres-Courchoud I1, Chen HH. Is there still a role for low-dose dopamine use in acute heart failure? Curr Opin Crit Care. 2014 Oct;20(5):467-71. doi: 10.1097/MCC.0000000000000133.
- Solinas M1, Ferré S, You ZB, Karcz-Kubicha M, Popoli P, Goldberg SR. Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J Neurosci. 2002 Aug 1;22(15):6321-4.
- Volkow ND1, Wang GJ1, Logan J2, Alexoff D2, Fowler JS2, Thanos PK2, Wong C1, Casado V3, Ferre S4, Tomasi D1. Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain. Transl Psychiatry. 2015 Apr 14;5:e549. doi: 10.1038/tp.2015.46.
- Salinas AG1, Davis MI2, Lovinger DM2, Mateo Y3. Dopamine dynamics and cocaine sensitivity differ between striosome and matrix compartments of the striatum. Neuropharmacology. 2016 Mar 29. pii: S0028-3908(16)30121-6. doi: 10.1016/j.neuropharm.2016.03.049. [Epub ahead of print]
- Field T1, Hernandez-Reif M, Diego M, Schanberg S, Kuhn C. Cortisol decreases and serotonin and dopamine increase following massage therapy. Int J Neurosci. 2005 Oct;115(10):1397-413.
- Fernstrom JD1, Fernstrom MH Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain. J Nutr. 2007 Jun;137(6 Suppl 1):1539S-1547S; discussion 1548S.
- Lou HC1. Dopamine precursors and brain function in phenylalanine hydroxylase deficiency. Acta Paediatr Suppl. 1994 Dec;407:86-8.
- Lucia Raffaella Lampariello,1 Alessio Cortelazzo,2 Roberto Guerranti,2 Claudia Sticozzi,3 and Giuseppe Valacchi3,4,* The Magic Velvet Bean of Mucuna pruriens Journal ListJ Tradit Complement Medv.2(4); Oct-Dec 2012PMC3942911
- Yokogoshi H1, Kobayashi M, Mochizuki M, Terashima T. Effect of theanine, r-glutamylethylamide, on brain monoamines and striatal dopamine release in conscious rats. Neurochem Res. 1998 May;23(5):667-73.
- Janssen PA1, Leysen JE, Megens AA, Awouters FH. Does phenylethylamine act as an endogenous amphetamine in some patients? Int J Neuropsychopharmacol. 1999 Sep;2(3):229-240.
Article last updated on: July 6th, 2018 by Nootriment